Want to join the conversation?
$CMG 2Q15 10-Q: Revenue was $1,197.8MM vs. $1,050.1MM in 2Q14. Net income was $140.2MM vs. $110.3MM in 2Q14. Income from operations was $227.4MM vs. $179.8MM in 2Q14. Operating expenses were $970.4MM vs. $870.2MM in 2Q14. Diluted EPS was $4.45 vs. $3.50 in 2Q14. Diluted weighted average common shares outstanding were 31,526 vs. 31,474 in 2Q14.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.